glp-1 drugs fda approved for weight loss New Pill Foundayo (Orforglipron) Gets Approval Obesity GLP-1s in the “Barbecue Belt

People who should not use GLP-1s include: Pregnant people People with a personal or family history of medullary thyroid cancer People with multiple endocrine neoplasia syndrome type 2, a rare condition that affects the endocrine glands People who are hypersensitive to GLP-1 agonist drugs GLP-1 Drugs Are Lifelong Treatments Questions to Ask Your Doctor Am I a candidate for a GLP-1 weight loss drug

9,1517 The primary outcomes assessed were BMI, headache, papilledema, visual disturbances, and refractory idiopathic IIH between GLP-1 group and control

Cost: Without insurance coverage, Ozempic can be prohibitively expensive, limiting access for some individuals

This suggests GLP-1 is the key player for appetite suppression and weight loss, with GIP providing enhancement rather than being equally important

Song, C., Long, X., He, J